Your browser doesn't support javascript.
loading
Primary cardiac lymphoma: the management and outcome of a single-centre cohort of 22 patients.
Wei, Xiao-Juan; Yuan, Hui; Khong, Pek-Lan; Zhang, Fen; Liao, Peng-Jun; Jiang, Xin-Miao; Huang, Ling; Guo, Han-Guo; Chen, Fei-Li; Liu, Si-Chu; Huang, Yan-Ying; Wang, Shu-Xia; Li, Wen-Yu.
Affiliation
  • Wei XJ; Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Yuan H; Department of Nuclear Medicine, Guangdong Academy of Medical Sciences & Guangdong Provincial People's Hospital, Guangzhou, Guangdong, P. R. China.
  • Khong PL; Department of Diagnostic Radiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.
  • Zhang F; Department of Pathology, Guangdong Academy of Medical Sciences & Guangdong Provincial People's Hospital, Guangzhou, Guangdong, P. R. China.
  • Liao PJ; Department of Haematology, Guangdong Academy of Medical Sciences & Guangdong Provincial People's Hospital, Guangzhou, Guangdong, P. R. China.
  • Jiang XM; Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Huang L; Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Guo HG; Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Chen FL; Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Liu SC; Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Huang YY; Department of Cardiology, Guangdong Academy of Medical Sciences & Guangdong Provincial People's Hospital, Guangzhou, Guangdong, P. R. China.
  • Wang SX; Department of Nuclear Medicine, Guangdong Academy of Medical Sciences & Guangdong Provincial People's Hospital, Guangzhou, Guangdong, P. R. China.
  • Li WY; Department of Clinical Oncology, Division of lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
Acta Oncol ; 60(9): 1122-1129, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34402368
ABSTRACT

BACKGROUND:

The incidence of primary cardiac lymphoma (PCL) is increasing, but the optimal management approach remains unclear. We assessed the clinical characteristics of a single-centre cohort with the goal of determining the optimal management approach. The treatment outcomes and prognostic factors are reported. MATERIAL AND

METHODS:

All PCL patients were diagnosed via biopsy guided by whole-body imaging (positron emission tomography/computed tomography [PET/CT] and/or contrast-enhanced CT]. Curative therapy involved either surgery or prephase steroids followed by definitive immunochemotherapy, depending on the histological type. The primary outcomes were overall survival (OS) and progression-free survival (PFS); the secondary outcome was the treatment response.

RESULTS:

Twenty-two PCL patients (14 males, 8 females; age 59.5 ± 14.7 years [mean ± S.D.]) were histologically confirmed to have diffuse large B-cell lymphoma (DLBCL; n = 17 [77.3%]), fibrin-associated DLBCL (FA-DLBCL) (n = 4 [18.2%]) and Burkitt lymphoma (n = 1 [4.5%]). Seven patients underwent cardiotomy (three for biopsy, four with curative intent). The median and longest follow-up periods were 16.3 and 180.0 months, respectively. The 16 patients who received curative therapy (complete response [CR], n = 15 [93.8%]; partial response [PR], n = 1 [6.2%]) showed better survival than those who did not (5-year OS 83.0 ± 11.3% vs. 0%; hazard ratio [HR] 0.025[95% confidence interval, CI 0.003-0.187], p < 0.001); 5-year PFS 78.7 ± 11.0% vs. 0%, HR= 0.010[0.001-0.093], p < 0.001). The left ventricular ejection fractions (LVEF) before and after definitive treatment was 63.6 ± 2.4% and 64.6 ± 4.5%, respectively (p = 0.275, power = 0.318). Extrapericardial lesions were associated with poorer survival (5-year OS 40.0 ± 29.7% vs. 100%, p = 0.027; 5-year PFS40.0 ± 21.9% vs. 100%, p = 0.010).

CONCLUSIONS:

Whole-body imaging is essential for diagnosis and prognosis. Curative therapy provided reasonable outcomes and survival; extrapericardial lesions were associated with a poorer treatment response.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Positron Emission Tomography Computed Tomography Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Positron Emission Tomography Computed Tomography Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article